Solventum is an independent healthcare company. Its business segment includes Medical Surgical, Dental Solutions, Health Information Systems and Purification and Filtration. Solventum is based in ST. PAUL, Minn.
| Revenue (Most Recent Fiscal Year) | $8.32B |
| Net Income (Most Recent Fiscal Year) | $1.56B |
| PE Ratio (Current Year Earnings Estimate) | 10.85 |
| PE Ratio (Trailing 12 Months) | 11.54 |
| PEG Ratio (Long Term Growth Estimate) | 1.15 |
| Price to Sales Ratio (Trailing 12 Months) | 1.47 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 2.42 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 7.83 |
| Pre-Tax Margin (Trailing 12 Months) | 20.58% |
| Net Margin (Trailing 12 Months) | 18.69% |
| Return on Equity (Trailing 12 Months) | 25.26% |
| Return on Assets (Trailing 12 Months) | 7.40% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.23 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.89 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 1.00 |
| Inventory Turnover (Trailing 12 Months) | 3.93 |
| Book Value per Share (Most Recent Fiscal Quarter) | $29.11 |
| Earnings per Share (Most Recent Fiscal Quarter) | $1.57 |
| Earnings per Share (Most Recent Fiscal Year) | $6.11 |
| Diluted Earnings per Share (Trailing 12 Months) | $8.87 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Health Information Services |
| Common Shares Outstanding | 173.49M |
| Free Float | 173.41M |
| Market Capitalization | $12.21B |
| Average Volume (Last 20 Days) | 1.15M |
| Beta (Past 60 Months) | 0.40 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.05% |
| Percentage Held By Institutions (Latest 13F Reports) | -- |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |